Competitor Analysis: Sphingosine-1-Phosphate (S1P) Receptor Modulators
Competitor Analysis: Sphingosine-1-Phosphate (S1P) Receptor Modulators
The Competitive Intelligence report about sphingosine-1-phosphate (S1P) receptor modulators provides a competitor analysis of approved or novel S1P receptor modulators for treatment of inflammatory and autoimmune diseases such as multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus, psoriasis and other inflammatory diseases as of September 2015. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active products and projects on the market or in research and development as specific sphingosine-1-phosphate (S1P) receptor modulators for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The Competitive Intelligence report about sphingosine-1-phosphate (S1P) receptor modulators provides a competitor analysis of approved or novel S1P receptor modulators for treatment of inflammatory and autoimmune diseases such as multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus, psoriasis and other inflammatory diseases as of September 2015. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active products and projects on the market or in research and development as specific sphingosine-1-phosphate (S1P) receptor modulators for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target/Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
S1P Receptor Modulators
Corporate S1P Receptor Modulator R&D Pipelines
Corporate S1P Receptor Modulator R&D Pipelines
